Koers iteos therapeutics
WebITeos Therapeutics has raised a total of $249.7M in funding over 8 rounds. Their latest funding was raised on Apr 1, 2024 from a Series B round. ITeos Therapeutics is registered under the ticker NASDAQ:ITOS . Their stock opened with $19.00 in its Jul 23, 2024 IPO. ITeos Therapeutics is funded by 17 investors. HBM Partners and Invus are the most ... WebiTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology …
Koers iteos therapeutics
Did you know?
WebMar 7, 2024 · iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno … WebMar 17, 2024 · iTeos Therapeutics, Inc. Common Stock (ITOS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
WebMar 24, 2024 · Bekijk hier de actuele koers van ITeos Therapeutics Inc (US46565G1040 / ITOS). Lees het meest recente nieuws en bekijk alle adviezen van analisten. WebApr 12, 2024 · 125. Free-Float. 99,3%. More Financials. Company. iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. The Company’s pipeline includes two clinical-stage programs targeting novel ...
WebStock analysis for iTeos Therapeutics Inc (ITOS:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. WebApr 13, 2024 · A high-level overview of iTeos Therapeutics, Inc. (ITOS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
WebJun 14, 2024 · iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno …
WebApr 12, 2024 · Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist … how tall is mark allenWebDec 9, 2024 · iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients. iTeos Therapeutics leverages its deep understanding of tumor immunology and immunosuppressive pathways to design novel product … messages to put in a maternity leave cardWebJun 14, 2024 · About iTeos Therapeutics, Inc. iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients. The Company’s innovative pipeline includes two clinical-stage programs targeting novel, validated … messages to put in a christmas cardWebGet the latest iTeos Therapeutics Inc (ITOS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment … messages to put in baby shower bookWebJul 27, 2024 · Company Overview. iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered just outside of Boston in Watertown, MA. The company also has a research center in Gosselies ... messages to put in maternity cardsWebMay 12, 2024 · Net Income/Loss: Net income attributable to common shareholders was $69.6 million, or net income of $1.96 per basic share and $1.82 per diluted share, for the quarter ended March 31, 2024, as ... how tall is marjanovicWebJun 4, 2024 · About iTeos Therapeutics, Inc. iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno ... messages to put on funeral flowers